InsidersTradesSigma
Track the CalciMedica, Inc. /DE/ stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €10.9m. The latest transaction was reported on 22 March 2023 (Attribution). Among the most active insiders: Roberts Eric W. Every trade is accessible without an account.
Analysts rate CalciMedica, Inc. /DE/ Strong Buy (bullish), based on 2 analysts. Average price target: US$10.50.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
CalciMedica, Inc. 是一家生物技术公司，专注于开发与钙调节相关的疾病治疗方法。该公司在纳斯达克上市，股票代码为 XNAS。